Summary of findings from the evaluation of a pilot medically supervised safer injecting facility
about
Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facilityThe law (and politics) of safe injection facilities in the United StatesThe cost-effectiveness of Vancouver's supervised injection facilityEstimated drug overdose deaths averted by North America's first medically-supervised safer injection facilitySupervised injection facilities in Canada: past, present, and futureCorrelates of public support toward federal funding for harm reduction strategies.Science and ideologyMitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facilityAn appeal to humanity: legal victory in favour of North America's only supervised injection facility: Insite.Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.A dynamic social systems model for considering structural factors in HIV prevention and detection.Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark.The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort studyOngoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy.The role of safer injection facilities in the response to HIV/AIDS among injection drug users.The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges.The need to promote public health in the field of illicit drug use.Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context.Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review.Decreasing Impact of Requiring Assistance Injecting on HIV Incidence."We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada.Rate of methadone use among Aboriginal opioid injection drug users.Declining rates of health problems associated with crack smoking during the expansion of crack pipe distribution in Vancouver, Canada.Canada's highest court unchains injection drug users; implications for harm reduction as standard of healthcareCommunity-based HIV prevention research among substance-using women in survival sex work: the Maka Project PartnershipDeclining trends in the rates of assisted injecting: a prospective cohort studyAntiviral agents and HIV prevention: controversies, conflicts, and consensus.Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage.The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugsTreatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV.Supervised injection sites: prejudice should not trump evidence of benefit."People knew they could come here to get help": an ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting.A qualitative study of the perceived effects of blue lights in washrooms on people who use injection drugsIntegrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population.HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada.Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico.Developing a scale of domains of negative consequences of chronic heroin use.Injecting drug use in low and middle-income countries: Opportunities to improve care and prevent harm.Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks.
P2860
Q24649575-873245DD-C6F3-4A32-B032-053A8696552EQ24657290-DA59E380-05AC-42B3-9480-F515BC2E321BQ24657903-10FC2A3A-7E6A-45D4-ACDD-9A2F5BFD5CABQ28473764-A1FDA22E-F8C6-4BD9-86C0-C81AB1F5EA49Q30234420-04328EF6-A1CA-4C4A-8DFF-F19178A8040BQ30279094-A5080ADF-7523-4199-B95E-A99DD1933D56Q33572831-BC17CD8E-9EA0-48AA-AC1E-52D6A53428EFQ33717043-D9CE3790-5151-4973-B3F3-C7FF7CB22BF1Q34221599-D910DEF0-3103-423E-A629-892960B7906BQ34251466-7F3C35AA-601C-4148-94C1-A59DF92FBAD3Q34425735-D83B91D9-017C-4418-8870-A7CE850486CFQ34484766-D5AE3EA1-E051-4F3E-AE56-84C010ECE9B9Q34582040-92E2AB8C-0360-4CEB-8CF5-290E8AA5BBACQ34735099-82FBA279-10EE-41D7-8BC0-E6394AFEFFB2Q34764625-F465E069-BC55-418F-9C3A-CBC475431BF2Q34954262-F4A444A3-B60A-46EB-98C3-0648811C790CQ35129254-25CEF792-3178-4AC1-9041-1F9BA4ACF0B2Q35137257-43A23899-6C39-477A-982F-9569504C243DQ35140126-41FF0FDC-F4D6-49BE-86AD-9FA053C1FDD6Q35580003-E7D6F632-530C-4342-A0C5-4CE6072718DAQ35744236-92FC5A06-EFF4-44D5-A415-AE64B698DB7EQ35850391-A4126F58-690E-4D5C-86B2-38F8491E61E9Q36270339-53F50D72-F094-4998-8A62-46FA11047B37Q36380319-43C1BC2E-FE19-44DE-A6F4-DF0490E35BCBQ36470099-1CD68F3C-9879-4814-BA22-841D09DBABBFQ36507947-E5D0DCD6-4326-4E44-9347-133C84F2755BQ36836680-CE0080F2-B426-4D6C-A904-31C13ED8FFCFQ37032437-F023A8BB-D062-440D-9530-E6EF7B62781FQ37062964-176ACE1B-B74C-4570-BEEE-E4FC5F8C7B21Q37117193-63306E1A-CD92-4420-B1E0-330C813ED251Q37229662-FD5FDFEE-18E5-4656-B2CF-81AA2F6FC888Q37274997-FD074B39-4294-4DFC-84CD-9A2E0719C987Q37368399-CB779DCA-89E3-4DA4-8B36-5D6482272F57Q37391641-310B0DD3-1B8F-488A-AC9A-200F3F5A18E9Q37521729-D02FDE05-7BEE-41CB-B7C0-EEA4E2F6BD8CQ37701769-EEE6A632-7D41-46FD-81AA-95922D83FAF5Q38621000-0173D7B6-169E-4C13-84FF-FFB1BEB5A803Q38653027-314FED00-D57C-4EF4-89AC-20AA972A8863Q38717150-C6AA7800-4C16-4644-B99A-C91428FD2EBAQ40107264-44103995-1D56-4695-AE77-D3F517340292
P2860
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Summary of findings from the e ...... vised safer injecting facility
@ast
Summary of findings from the e ...... vised safer injecting facility
@en
Summary of findings from the e ...... vised safer injecting facility
@nl
type
label
Summary of findings from the e ...... vised safer injecting facility
@ast
Summary of findings from the e ...... vised safer injecting facility
@en
Summary of findings from the e ...... vised safer injecting facility
@nl
prefLabel
Summary of findings from the e ...... vised safer injecting facility
@ast
Summary of findings from the e ...... vised safer injecting facility
@en
Summary of findings from the e ...... vised safer injecting facility
@nl
P2860
P50
P356
P1476
Summary of findings from the e ...... vised safer injecting facility
@en
P2093
Julio S Montaner
P2860
P304
P356
10.1503/CMAJ.060863
P407
P577
2006-11-01T00:00:00Z